Sunday, October 31, 2021 10:24:45 PM
While Nader Pourhassan Ph. D. is working to get Leronlimab approved
YOU might want to consider a few other factors:
Do you know someone with cancer? If you don't you will, sooner or later. How about someone who has had a stroke or died from stroke - know anyone?
Or do you enjoy the great American Diet? Have you ever heard of NASH?
Probably not - but it's believed to effect one third of the US population and THERE IS NO CURRENT REMEDY.
How about AIDS (HIV) - know anybody afflicted with this tragic disease?
All of these diseases/afflictions can be ameliorated (helped) by Leronlimab. Yes, all of the above "problems, besides, Covid-19" AND MANY MORE AS WELL.
***
This drug is "UNIQUE" >>>>> KEY CONSIDERATION IS LERONLIMAB DOESN'T HAVE ANY MAJOR NEGATIVE SIDE EFFECTS!!
Just watch those TV ads for various drugs (about 30% of all ads - over 5 billion dollars worth of advertising [2020 info]) and as they tell you about the amazing drug and what it's going to do for you...
>>>>>The Pharma company owning the drug also has to present some of its potential negative side effects.
So they do !!! Quickly they run through the lengthy list of bad things that can happen to you if you take their drug...(Normally they have "distracting things going on in the background - people jumping into pools with a big splash, building playgrounds, handing out boxes of stuff to less fortunate, wild party dancing, etc.).
Leronlimab doesn't have these lengthy lists of really bad side effects (maybe a swollen gland(s) for a day or two, irritation at the injection site, minor diarrhea, minor stuff for a short time).
For this reason LERONLIMB is dangerous!!!!!
Dangerous to the other pharmaceutical company's drug lines that DO have very bad side effects!!!
So that's what this (according to some ????) very bad guy - Nader Pourhassan Ph. D., is doing, he's trying to make Leronlimab available to YOU.
Hey, "Bad Guy Nader Pourhassan Ph. D." - please don't quit!! we want leronlimab and we want it NOW...Keep on Keeping on and ignore the insults, smears, character assassination, lies, etc.
Cheering for your/our success!!
Go Leronlimab!
IMO
YOU might want to consider a few other factors:
Do you know someone with cancer? If you don't you will, sooner or later. How about someone who has had a stroke or died from stroke - know anyone?
Or do you enjoy the great American Diet? Have you ever heard of NASH?
Probably not - but it's believed to effect one third of the US population and THERE IS NO CURRENT REMEDY.
How about AIDS (HIV) - know anybody afflicted with this tragic disease?
All of these diseases/afflictions can be ameliorated (helped) by Leronlimab. Yes, all of the above "problems, besides, Covid-19" AND MANY MORE AS WELL.
***
This drug is "UNIQUE" >>>>> KEY CONSIDERATION IS LERONLIMAB DOESN'T HAVE ANY MAJOR NEGATIVE SIDE EFFECTS!!
Just watch those TV ads for various drugs (about 30% of all ads - over 5 billion dollars worth of advertising [2020 info]) and as they tell you about the amazing drug and what it's going to do for you...
>>>>>The Pharma company owning the drug also has to present some of its potential negative side effects.
So they do !!! Quickly they run through the lengthy list of bad things that can happen to you if you take their drug...(Normally they have "distracting things going on in the background - people jumping into pools with a big splash, building playgrounds, handing out boxes of stuff to less fortunate, wild party dancing, etc.).
Leronlimab doesn't have these lengthy lists of really bad side effects (maybe a swollen gland(s) for a day or two, irritation at the injection site, minor diarrhea, minor stuff for a short time).
For this reason LERONLIMB is dangerous!!!!!
Dangerous to the other pharmaceutical company's drug lines that DO have very bad side effects!!!
So that's what this (according to some ????) very bad guy - Nader Pourhassan Ph. D., is doing, he's trying to make Leronlimab available to YOU.
Hey, "Bad Guy Nader Pourhassan Ph. D." - please don't quit!! we want leronlimab and we want it NOW...Keep on Keeping on and ignore the insults, smears, character assassination, lies, etc.
Cheering for your/our success!!
Go Leronlimab!
IMO
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
